Worth reading
79Important
Scored from 5 of 6 sectionsDirection
Improvement
Direction inferred from the company’s description.Scale
82.3
Year-on-year change in operating profit (%)Wording
Conditional
How definitive the wording is.Contents of this document
Financial results presentationFirst quarter of the fiscal year ending March 20279 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥4,900 million+2.5%
Operating profit¥615 million+82.3%
Ordinary income¥642 million+94.0%
Net income¥455 million+118.9%
Operating profit margin12.6%, up 5.5 percentage points year on year
Results for the three months of the current quarterFor the first quarter of the fiscal year ending March 2027, net sales were ¥4,900 million, operating profit was ¥615 million, ordinary profit was ¥642 million, and net profit attributable to owners of the parent was ¥455 million.
Full-year earnings forecast
Net Sales
¥21,700 million
Operating profit
¥2,300 million
Ordinary income
¥2,340 million
Net income attributable to owners of the parent
¥1,260 million
Ordinary income margin
10.8 %
ROE
12.5 %
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales22.5 %
Chemicals business net sales25.6 %
Various salts business net sales11.2 %
Operating profit26.7 %
Chemicals business operating profit24.5 %
Various salts business operating profit6.6 %
Ordinary income27.4 %
Net income attributable to owners of the parent36.1 %
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Although progress toward the full-year net sales plan was below average, profit progress exceeded the average rate.Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Volume variance¥-1.8 100 million
Selling price variance¥3 100 million
Unit cost variance¥1.1 100 million
Selling, general and administrative expenses¥0.5 100 million
Other¥0.3 100 million
New initiatives
Introduction of a shareholder benefit program, timely and appropriate revisions to selling prices, and reductions in manufacturing costs through the optimization of electrolysis operationsUnit price and quantity metricsThese figures show sales broken down by price and volume.
Sales volume of various salt products
First quarter of the fiscal year ending March 202615.3 thousand tonnes
First quarter of the fiscal year ending March 202713.2 thousand tonnes
Year on year against the same period last year-14.0%
Segment results
Chemicals Business
Net Sales
¥4,377 million+3.7%
Segment profit
¥833 million+39.5%
Various salt products business
Net Sales
¥522 million-6.6%
Segment profit
¥24 million+0.1%
Financial targets
ROE
Outlook for the fiscal year ending March 202712.5 %
Equity ratio
End of June 202658.9 %
Annual Dividend
Fiscal year ending March 2027
Annual¥65
Interim¥30
End of period¥35
Payout ratio
Fiscal year ending March 202710.4 %
After taking shareholder benefits into account15.2 %
Acquisition of treasury shares
Fiscal year ending March 2026
Number of shares acquired40,700
Acquisition price150
Purchase price unit¥ million
| Item | Details |
|---|---|
| Document type | Financial results presentation |
| Fiscal Period Covered | First quarter of the fiscal year ending March 2027 |
| Net Sales | ¥4,900 million (YoY +2.5%) |
| Operating profit | ¥615 million (YoY +82.3%) |
| Ordinary income | ¥642 million (YoY +94.0%) |
| Net income | ¥455 million (YoY +118.9%) |
| Operating profit margin | 12.6%, up 5.5 percentage points year on year |
| Results for the three months of the current quarter | For the first quarter of the fiscal year ending March 2027, net sales were ¥4,900 million, operating profit was ¥615 million, ordinary profit was ¥642 million, and net profit attributable to owners of the parent was ¥455 million. |
| Full-year earnings forecast | Net Sales ¥21,700 million / Operating profit ¥2,300 million / Ordinary income ¥2,340 million / Net income attributable to owners of the parent ¥1,260 million / Ordinary income margin 10.8 % / ROE 12.5 % |
| Progress against full-year forecast | Net Sales 22.5 % / Chemicals business net sales 25.6 % / Various salts business net sales 11.2 % / Operating profit 26.7 % / Chemicals business operating profit 24.5 % / Various salts business operating profit 6.6 % / Ordinary income 27.4 % / Net income attributable to owners of the parent 36.1 % |
| Self-assessment against the plan | Although progress toward the full-year net sales plan was below average, profit progress exceeded the average rate. |
| Segment results | Chemicals Business Net Sales ¥4,377 million (YoY +3.7%) / Segment profit ¥833 million (YoY +39.5%) / Various salt products business Net Sales ¥522 million (YoY -6.6%) / Segment profit ¥24 million (YoY +0.1%) |
| Breakdown of Factors Affecting the Change | Volume variance ¥-1.8 100 million / Selling price variance ¥3 100 million / Unit cost variance ¥1.1 100 million / Selling, general and administrative expenses ¥0.5 100 million / Other ¥0.3 100 million |
| Unit price and quantity metrics | Sales volume of various salt products First quarter of the fiscal year ending March 2026 15.3 thousand tonnes / First quarter of the fiscal year ending March 2027 13.2 thousand tonnes / Year on year against the same period last year -14 |
| Financial targets | ROE Outlook for the fiscal year ending March 2027 12.5 % / Equity ratio End of June 2026 58.9 % |
| Annual Dividend | Fiscal year ending March 2027 Annual ¥65 / Interim ¥30 / End of period ¥35 |
| Payout ratio | Fiscal year ending March 2027 10.4 % / After taking shareholder benefits into account 15.2 % |
| Acquisition of treasury shares | Fiscal year ending March 2026 Number of shares acquired 40,700 / Acquisition price 150 / Purchase price unit ¥ million |
| New initiatives | Introduction of a shareholder benefit program, timely and appropriate revisions to selling prices, and reductions in manufacturing costs through the optimization of electrolysis operations |
Items this document does not state (12)
Gross Profit MarginSelling, general and administrative expensesKey KPIsNumber of stores and locationsNumber of employeesAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookMedium-term management plan targetsCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although sales volume declined due to shrinking demand in certain transactions and withdrawal from transactions as part of a strategy of selection and concentration, the Company worked to revise selling prices in a timely and appropriate manner, reduce manufacturing costs by optimizing electrolysis operations, and cut selling, general and administrative expenses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.